Related Experiment Video

Updated: Jun 20, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Towards the definition of prostate cancer-related microRNAs: where are we now?

Paolo Gandellini1, Marco Folini, Nadia Zaffaroni

  • 1Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Trends in Molecular Medicine
|September 1, 2009
PubMed

Insights

Identifying microRNAs in prostate cancer is challenging due to inconsistent data. This review proposes a rational approach to validate microRNAs for advanced prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Advanced prostate cancer eradication remains a significant clinical challenge.
  • Understanding molecular changes is crucial for identifying new therapeutic targets.
  • MicroRNAs are implicated in human tumors, acting as oncogenes or tumor suppressors.

Purpose of the Study:

  • To review challenges in identifying prostate cancer-related microRNAs.
  • To propose a rational approach for validating clinically relevant microRNAs.
  • To aid in the development of alternative treatment strategies for advanced prostate cancer.

Main Methods:

  • Literature review of studies on microRNA expression and function in prostate cancer.
  • Analysis of factors contributing to inconsistent data in previous research.
  • Development of a framework for rational validation of candidate microRNAs.

Main Results:

  • Previous studies on prostate cancer microRNAs have yielded inconsistent data.
  • Several factors hinder the accurate identification of relevant microRNAs.
  • A systematic approach is needed for reliable microRNA candidate validation.

Conclusions:

  • Consistent identification of prostate cancer-related microRNAs is hampered by methodological issues.
  • A structured validation strategy is essential for clinical relevance.
  • Validated microRNAs could offer novel therapeutic targets for advanced prostate cancer management.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...